Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylaxis of Complications of Basic Therapy and Medical Rehabilitation Using Naderin in Socially Significant Diseases, Including Malignant Neoplasms, Tuberculosis, and Hepatitis C

NCT07671508 is registered in ClinicalTrials.gov with MIPO Clinic as lead sponsor.

NCT NCT07671508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07671508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylaxis of Complications of Basic Therapy and Medical Rehabilitation Using Naderin in Socially Significant Diseases, Including Malignant Neoplasms, Tuberculosis, and Hepatitis C
Lead sponsor
MIPO Clinic
Phase
Phase 2/3
Overall status
Completed
Start date
May 15, 2013
Completion date
March 12, 2014
Enrollment
75 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c (hcv), malignant neoplasms, tuberculosis (tb)